INmune Bio
INMB
#8909
Rank
ยฃ79.3 M
Marketcap
ยฃ3.58
Share price
-1.32%
Change (1 day)
-58.02%
Change (1 year)

Operating Margin for INmune Bio (INMB)

Operating Margin as of December 2024 (TTM): -26,333.60%

According to INmune Bio's latest financial reports and stock price the company's current Operating Margin is -26,333.60%. At the end of 2023 the company had an Operating Margin of -19,360.00%.

Operating Margin history for INmune Bio from 2021 to 2024

202220232024-25000 %-20000 %-15000 %-10000 %-5000 %5000 %0companiesmarketcap.com

Operating Margin at the end of each year

Year Operating Margin Change
2023-19,360.00%165.23%
2022-7,299.20%-56.46%
2021-16,762.43%-84.76%
2020-109,990.91%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.